Erratum to ＂Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy＂

Perrone, L., Matrone, C., & Singh, L. P. (2014). Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy. Journal of Ophthalmology, (2014-3), 323-332. https://doi.org/10.1155/2014/789120
Hsu, Y. J. (2021). Implication of Fenofibrate for Diabetic Retinopathy Treatment [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202100719
王律鈞（2010）。Oxidative Stress and Diabetic Retinopathy。中華民國眼科醫學會雜誌，49(2)，133-136。https://doi.org/10.30048/ACTASOS.201006.0003
Zorena, K. (2014). Anti-Inflammatory Therapy in Diabetic Retinopathy. Mediators of Inflammation, (2014-9), 393-394. https://doi.org/10.1155/2014/947896
Chen, M. S., Kao, C. S., Chang, C. J., Wu, T. J., Fu, C. C., Chen, C. J., & Tai, T. Y. (1994). Epidemiology of Diabetic Retinopathy. Journal of Genetics and Molecular Biology, 5(4), 72-72. https://doi.org/10.30047/JGMB.199412.0003